GS Intragenic Complementation Vectors for Heteromeric Protein Selection

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods for expressing heteromeric recombinant proteins require screening of many clones to identify rare high-expressing cells and often result in unnecessary synthesis of incomplete protein chains, necessitating a more efficient selection system.

Innovation Solution

A vector system utilizing intragenic complementation of glutamine synthetase, where N-terminal and C-terminal mutant subunits of the enzyme are split and operably linked with selectable marker fragments, enabling efficient expression and selection of heteromeric complexes in mammalian cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional screening methods are used to identify high-expressing clones, then rare high-expressing cells can be identified, but the process requires screening of many clones and takes significant time

Engineering Contradiction:

Improveidentification accuracy of high-expressing cellsVSAvoidtime required for clone screening

Core Design Contradiction:

Measurement precisionVSLoss of time

Solution Approach 1:

The selectable marker (glutamine synthetase) is divided into two non-functional mutant subunits that must complement each other to restore enzymatic activity. This segmentation allows the system to distinguish cells expressing both heteromeric protein chains simultaneously, enabling direct selection of high-expressing clones without extensive screening

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The intragenic complementation system acts as an intermediary mechanism between gene expression and phenotypic selection. By using the glutamine synthetase complementation system as a mediator, the patent transforms the selection process from time-consuming phenotypic screening to efficient enzymatic activity-based selection

Inventive Principle:

Principle #24Intermediary (Mediator)

2Productivity

If traditional expression systems are used, then heteromeric proteins can be produced, but unnecessary synthesis of incomplete protein chains occurs

Engineering Contradiction:

Improveheteromeric protein productionVSAvoidwaste of incomplete protein chains

Core Design Contradiction:

ProductivityVSLoss of substance

Solution Approach 1:

By dividing the selectable marker into two complementary mutant subunits and linking each to a different heteromeric protein chain, the system ensures that only cells expressing both chains in proper proportions can restore enzymatic activity and survive selection, eliminating waste of incomplete chains

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The system changes the selection parameter from general cell transfection to specific co-expression of both chains by requiring intragenic complementation. This parameter change ensures that selection pressure favors cells with balanced expression of both protein chains, reducing synthesis of unnecessary incomplete chains

Inventive Principle:

Principle #35Parameter changes

3Reliability

If split selectable marker systems are used, then cells expressing both marker fragments can be identified, but the system complexity increases

Engineering Contradiction:

Improveselection accuracy for heteromeric expressionVSAvoidvector system complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses the natural intragenic complementation property of glutamine synthetase as an intermediary mechanism to simplify the overall system. Rather than creating entirely new complex selection systems, it leverages the existing biological phenomenon of intragenic complementation to achieve reliable selection

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The glutamine synthetase intragenic complementation system serves multiple functions: it acts as a selectable marker, a co-expression verification system, and a proportionality control mechanism simultaneously. This multi-functionality reduces the need for separate selection systems while maintaining reliability

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This system allows for the rapid identification of cells expressing high levels of heteromeric proteins, such as antibodies, by restoring enzymatic activity only when both subunits are present, thereby improving selection efficiency and reducing the time required to achieve high expression levels.

Implementation Method 1

Genetic studies in S. cerevisiae and E. coli showed that certain GS mutations displayed intragenic complementation, where some mutations that mapped to the 5′ end of the GS gene could complement those in the 3′ end

Methodology Applied

Scientific EffectIntragenic complementation:

Implementation Method 2

Glutamine synthetase (GS) catalyzes glutamine biosynthesis by the condensation of ammonia with glutamate

Methodology Applied

Scientific EffectEnzymatic catalysis: Catalysis

Data Source

PatentUS12516111B2Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors

Publication Date: 2026.01.06 AMGEN INC

AI summary

This invention relates to the general field of recombinant expression of polypeptides in animal cell culture. More specifically, the invention concerns improved selection of cells transfected with recombinantly engineered vectors designed to express polypeptides, in particular heteromultimeric polypeptides.